Literature DB >> 23055295

Prevalence and abundance of Staphylococcus aureus in the middle meatus of patients with chronic rhinosinusitis, nasal polyps, and asthma.

Vijay R Ramakrishnan1, Leah M Feazel, Leah J Abrass, Daniel N Frank.   

Abstract

BACKGROUND: Chronic rhinosinusitis (CRS) is an idiosyncratic and multifactorial disease process. Bacteria play a role in some patients, by infection or stimulation of inflammation. Staphylococcus aureus (SA) appears to be implicated in a number of infectious and inflammatory mechanisms, and may be particularly relevant in CRS patients with nasal polyps and asthma.
METHODS: Middle meatus swabs from control and CRS patients collected during endoscopic sinus surgery were analyzed by quantitative polymerase chain reaction (QPCR). Total bacterial count, SA prevalence, and SA abundance were examined with respect to patient demographics and disease characteristics.
RESULTS: Total bacteria, as measured by QPCR, was not statistically different between controls, CRS without nasal polyps (CRSsNP), CRS with nasal polyps (CRSwNP), or CRS with asthma groups (p < 0.09). Total bacterial counts did not correlate with disease severity as measured by Lund-Mackay computed tomography (CT) scores (p = 0.65). The prevalence of SA was similar between groups (15-25%); however, the abundance increased in CRS patients with allergic rhinitis, nasal polyps, and asthma.
CONCLUSION: The paranasal sinuses are not sterile. SA is implicated in a subset of CRS patients with nasal polyps and/or asthma. Further study is required to predict this subset of patients, and to define the mechanisms of SA pathogenesis.
© 2013 ARS-AAOA, LLC.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23055295     DOI: 10.1002/alr.21101

Source DB:  PubMed          Journal:  Int Forum Allergy Rhinol        ISSN: 2042-6976            Impact factor:   3.858


  20 in total

Review 1.  Microbiome of the paranasal sinuses: Update and literature review.

Authors:  Jivianne T Lee; Daniel N Frank; Vijay Ramakrishnan
Journal:  Am J Rhinol Allergy       Date:  2016 Jan-Feb       Impact factor: 2.467

Review 2.  Bacterial Pathogens and the Microbiome.

Authors:  Thad W Vickery; Vijay R Ramakrishnan
Journal:  Otolaryngol Clin North Am       Date:  2017-02       Impact factor: 3.346

Review 3.  A comprehensive review of the nasal microbiome in chronic rhinosinusitis (CRS).

Authors:  M Mahdavinia; A Keshavarzian; M C Tobin; A L Landay; R P Schleimer
Journal:  Clin Exp Allergy       Date:  2016-01       Impact factor: 5.018

Review 4.  The Role of Staphylococcus aureus in Patients with Chronic Sinusitis and Nasal Polyposis.

Authors:  Thad W Vickery; Vijay R Ramakrishnan; Jeffrey D Suh
Journal:  Curr Allergy Asthma Rep       Date:  2019-03-11       Impact factor: 4.806

Review 5.  The Etiology and Pathogenesis of Chronic Rhinosinusitis: a Review of Current Hypotheses.

Authors:  Kent Lam; Robert Schleimer; Robert C Kern
Journal:  Curr Allergy Asthma Rep       Date:  2015-07       Impact factor: 4.806

6.  Composition of nasal bacterial community and its seasonal variation in health care workers stationed in a clinical research laboratory.

Authors:  Nazima Habibi; Abu Salim Mustafa; Mohd Wasif Khan
Journal:  PLoS One       Date:  2021-11-24       Impact factor: 3.240

Review 7.  The sinonasal bacterial microbiome in health and disease.

Authors:  Vijay R Ramakrishnan; Leah J Hauser; Daniel N Frank
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2016-02       Impact factor: 2.064

Review 8.  Risks for infection in patients with asthma (or other atopic conditions): is asthma more than a chronic airway disease?

Authors:  Young J Juhn
Journal:  J Allergy Clin Immunol       Date:  2014-08       Impact factor: 10.793

9.  Understanding the Role of Biofilms and Superantigens in Chronic Rhinosinusitis.

Authors:  Ivy W Maina; Neil N Patel; Noam A Cohen
Journal:  Curr Otorhinolaryngol Rep       Date:  2018-07-26

10.  Anaerobic Microbiota Derived from the Upper Airways Impact Staphylococcus aureus Physiology.

Authors:  Sarah K Lucas; Alex R Villarreal; Madison M Ahmad; Abayo Itabiyi; Erin Feddema; Holly C Boyer; Ryan C Hunter
Journal:  Infect Immun       Date:  2021-08-16       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.